LT3046537T - Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui - Google Patents

Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui

Info

Publication number: LT3046537T
Authority: LT; Lithuania
Prior art keywords: hydrocarbonic; therapeutic use; pharmaceutical form; pharmaceutical; therapeutic
Prior art date: 2013-09-16

Application number

LTEPPCT/US2014/055921T

Other languages

English (en)

Lithuanian (lt)

Inventor

Agnes RAFALKO

Tatyana CHERNENKO

Original Assignee

Glycomine, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-16

Filing date

2014-09-16

Publication date

2021-12-10

2014-09-16 Application filed by Glycomine, Inc. filed Critical Glycomine, Inc.

2021-12-10 Publication of LT3046537T publication Critical patent/LT3046537T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

LTEPPCT/US2014/055921T 2013-09-16 2014-09-16 Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui LT3046537T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361878591P	2013-09-16	2013-09-16
PCT/US2014/055921 WO2015053910A2 (fr)	2013-09-16	2014-09-16	Préparation pharmaceutique de glucides à usage thérapeutique

Publications (1)

Publication Number	Publication Date
LT3046537T true LT3046537T (lt)	2021-12-10

Family

ID=52813726

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEPPCT/US2014/055921T LT3046537T (lt)	2013-09-16	2014-09-16	Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
LTEP21185152.2T LT3954360T (lt)	2013-09-16	2014-09-16	Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LTEP21185152.2T LT3954360T (lt)	2013-09-16	2014-09-16	Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui

Country Status (15)

Country	Link
US (6)	US20160228364A1 (fr)
EP (3)	EP3954360B1 (fr)
CY (1)	CY1125361T1 (fr)
DK (2)	DK3046537T3 (fr)
ES (2)	ES2892314T3 (fr)
FI (1)	FI3954360T3 (fr)
HR (2)	HRP20250522T1 (fr)
HU (2)	HUE071419T2 (fr)
LT (2)	LT3046537T (fr)
PL (2)	PL3046537T3 (fr)
PT (2)	PT3954360T (fr)
RS (2)	RS62641B1 (fr)
SI (2)	SI3046537T1 (fr)
SM (2)	SMT202500160T1 (fr)
WO (1)	WO2015053910A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR119705A1 (es) *	2019-03-29	2022-01-05	Glycomine Inc	Formulaciones liposomales y sus métodos de uso y preparación
US11058637B1 (en) *	2020-11-25	2021-07-13	King Abdulaziz University	Surface-modified emulsomes for intranasal delivery of drugs
KR20250016197A (ko) *	2022-05-18	2025-02-03	글라이코민 인코포레이티드	만노스-1-포스페이트를 생산하기 위한 연속 흐름 방법, 만노스-1-포스페이트의 다형체, 및 이와 관련된 조성물 및 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5013556A (en) *	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US7189705B2 (en) *	2000-04-20	2007-03-13	The University Of British Columbia	Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) *	2000-05-09	2006-03-14	Mcp Hahnemann University	β-glucans encapsulated in liposomes
US7914714B2 (en) *	2003-05-14	2011-03-29	The Regents Of The University Of Colorado	Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr) *	2006-02-24	2009-04-17	Orphan Europ Sarl	Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
CN102046151A (zh)	2008-03-26	2011-05-04	牛津大学	靶向内质网的脂质体
US20120135064A1 (en) *	2009-05-27	2012-05-31	Northeastern University	Conjugated nanodelivery vehicles
MX348474B (es)	2009-12-23	2017-06-14	Novartis Ag *	Lipidos, composiciones de lipido, y metodos de uso de los mismos.
US20110257233A1 (en)	2010-03-19	2011-10-20	Sanford-Burnham Medical Research Institute	Benzoisothiazolones as inhibitors of phosphomannose isomerase
CA2807141C (fr) *	2010-07-31	2019-02-26	The Scripps Research Institute	Compositions et methodes pour induire la tolerance immunitaire

2014
- 2014-09-16 EP EP21185152.2A patent/EP3954360B1/fr active Active
- 2014-09-16 PL PL14851464T patent/PL3046537T3/pl unknown
- 2014-09-16 RS RS20211212A patent/RS62641B1/sr unknown
- 2014-09-16 SI SI201431883T patent/SI3046537T1/sl unknown
- 2014-09-16 WO PCT/US2014/055921 patent/WO2015053910A2/fr not_active Ceased
- 2014-09-16 HU HUE21185152A patent/HUE071419T2/hu unknown
- 2014-09-16 EP EP25157136.0A patent/EP4563152A3/fr active Pending
- 2014-09-16 HR HRP20250522TT patent/HRP20250522T1/hr unknown
- 2014-09-16 FI FIEP21185152.2T patent/FI3954360T3/fi active
- 2014-09-16 PT PT211851522T patent/PT3954360T/pt unknown
- 2014-09-16 ES ES14851464T patent/ES2892314T3/es active Active
- 2014-09-16 LT LTEPPCT/US2014/055921T patent/LT3046537T/lt unknown
- 2014-09-16 SI SI201432105T patent/SI3954360T1/sl unknown
- 2014-09-16 SM SM20250160T patent/SMT202500160T1/it unknown
- 2014-09-16 PL PL21185152.2T patent/PL3954360T3/pl unknown
- 2014-09-16 EP EP14851464.9A patent/EP3046537B1/fr active Active
- 2014-09-16 RS RS20250391A patent/RS66755B1/sr unknown
- 2014-09-16 DK DK14851464.9T patent/DK3046537T3/da active
- 2014-09-16 ES ES21185152T patent/ES3026657T3/es active Active
- 2014-09-16 LT LTEP21185152.2T patent/LT3954360T/lt unknown
- 2014-09-16 HU HUE14851464A patent/HUE056624T2/hu unknown
- 2014-09-16 SM SM20210570T patent/SMT202100570T1/it unknown
- 2014-09-16 PT PT14851464T patent/PT3046537T/pt unknown
- 2014-09-16 US US15/022,194 patent/US20160228364A1/en not_active Abandoned
- 2014-09-16 DK DK21185152.2T patent/DK3954360T3/da active
- 2014-09-16 HR HRP20211564TT patent/HRP20211564T1/hr unknown
2017
- 2017-10-19 US US15/788,591 patent/US10449149B2/en active Active
2019
- 2019-09-11 US US16/568,098 patent/US11045419B2/en active Active
2021
- 2021-05-21 US US17/327,241 patent/US20220110871A1/en not_active Abandoned
- 2021-10-05 CY CY20211100863T patent/CY1125361T1/el unknown
2023
- 2023-03-30 US US18/193,328 patent/US20240082155A1/en not_active Abandoned
2024
- 2024-07-18 US US18/777,142 patent/US20250186345A1/en active Pending

Also Published As

Publication number	Publication date
EP3954360A2 (fr)	2022-02-16
PT3954360T (pt)	2025-04-30
US20240082155A1 (en)	2024-03-14
DK3954360T3 (da)	2025-05-12
EP3046537B1 (fr)	2021-07-14
HUE071419T2 (hu)	2025-08-28
LT3954360T (lt)	2025-05-12
US11045419B2 (en)	2021-06-29
EP4563152A3 (fr)	2025-11-19
US20250186345A1 (en)	2025-06-12
HRP20211564T1 (hr)	2022-01-21
CY1125361T1 (el)	2023-03-24
US20160228364A1 (en)	2016-08-11
SI3954360T1 (sl)	2025-06-30
SI3046537T1 (sl)	2022-01-31
PT3046537T (pt)	2021-10-07
ES2892314T3 (es)	2022-02-03
PL3954360T3 (pl)	2025-07-07
RS66755B1 (sr)	2025-05-30
EP3046537A4 (fr)	2017-04-19
PL3046537T3 (pl)	2022-01-31
EP3954360B1 (fr)	2025-02-12
WO2015053910A3 (fr)	2015-06-18
US20220110871A1 (en)	2022-04-14
WO2015053910A2 (fr)	2015-04-16
US10449149B2 (en)	2019-10-22
EP3954360A3 (fr)	2022-06-01
FI3954360T3 (fi)	2025-05-15
US20200246266A1 (en)	2020-08-06
ES3026657T3 (en)	2025-06-11
HUE056624T2 (hu)	2022-02-28
DK3046537T3 (da)	2021-10-11
US20180036239A1 (en)	2018-02-08
SMT202100570T1 (it)	2022-01-10
SMT202500160T1 (it)	2025-05-12
HRP20250522T1 (hr)	2025-06-20
EP4563152A2 (fr)	2025-06-04
EP3046537A2 (fr)	2016-07-27
RS62641B1 (sr)	2021-12-31

Publication	Publication Date	Title
FR21C1059I1 (fr)	2022-01-21	Compositions pharmaceutiques
DK3030262T3 (da)	2019-12-02	Kombineret farmaceutisk sammensætning
DK2983721T4 (da)	2021-02-01	Terapeutiske indgivelsesvesikler
BR112016009485A2 (pt)	2017-08-01	Inalador de medicamento
DK3062849T3 (da)	2023-09-25	Medikamentadministrationsanordning
HUE037275T2 (hu)	2018-08-28	Gyógyszer-kombináció
DK3038674T3 (da)	2020-02-24	Medikamentafgivelsesindretning
DK3287133T3 (da)	2019-07-01	Proton-bindende polymerer til oral indgivelse
DK2767269T3 (da)	2019-05-06	Terapeutisk anordning
LT3563837T (lt)	2021-12-27	Terapija bakteriofagu
DK3363428T3 (da)	2024-05-21	Perfusionsdoseringsform
FI20135231A7 (fi)	2014-09-12	Potilasalusta
DK3590499T3 (da)	2022-10-31	Inhalerbare lægemidler
DK3079667T3 (da)	2019-09-09	Farmaceutiske doseringsformer
EP4233950C0 (fr)	2025-06-25	Administration par voie nasale
DK3003401T3 (da)	2020-04-06	Farmaceutisk præparat
DK3043845T3 (da)	2017-11-06	Lægemiddelfremføringsanordning
DK2958935T3 (da)	2019-09-16	Vaccine
LT3046537T (lt)	2021-12-10	Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
DK2983747T3 (da)	2020-02-24	Lægemiddelindgivelsesindretning
DK2897588T3 (da)	2019-08-12	Inhalerbart lægemiddel
HRP20171888T1 (hr)	2018-01-12	Farmaceutski pripravci
EP2958932A4 (fr)	2016-08-10	Agents thérapeutiques
UA30187S (uk)	2015-09-10	Ампула
UA28338S (uk)	2014-11-10	Медичний пристрій-шприц